文献速递肺外科心外重症与机械循环支持

基于诊断的肺移植差异:ECMO桥接患者中PAH移植率更低

Lung transplantation disparities based on diagnosis for patients bridging to transplant on extracorporeal membrane oxygenation.
PubMed 文献 · J Heart Lung Transplant · 2021-08-25

该回顾性队列研究利用UNOS数据纳入2015年6月至2020年6月期间≥12岁、在肺移植等待名单上且需要ECMO支持的1064例患者,比较不同诊断患者的移植结局。结果显示,与PAH患者相比,OLD、CF和ILD患者接受移植的可能性分别高78%、69%和62%(校正SHR分别为1.78、1.69、1.62)。

要点

  • ECMO桥接肺移植患者中,PAH诊断与更低的移植率独立相关。
  • OLD、CF、ILD患者移植可能性较PAH分别高78%、69%、62%。
  • PAH患者移除等待名单时中位LAS为79.6,高于OLD但低于CF和ILD。

核心结论

  • 在ECMO桥接肺移植的等待名单患者中,PAH患者的移植率显著低于OLD、CF和ILD患者。

研究设计与样本

  • 利用UNOS数据的回顾性队列研究,纳入2015年6月1日至2020年6月12日期间≥12岁、活跃在肺移植等待名单且需要ECMO支持的1064例患者。
  • 采用多变量竞争风险分析检验等待名单结局。

主要发现

  • 1064例ECMO支持等待者中,OLD占3.8%(40例),PAH占9.1%(97例),CF占13.0%(138例),ILD占74.1%(789例)。
  • 最终671例(63.1%)接受移植,334例(31.4%)死亡或退出等待名单。
  • ECMO等待期间每 person-years 移植率:OLD 15.41,PAH 6.05,CF 15.66,ILD 15.62。
  • 与PAH相比,OLD、CF、ILD患者接受移植的校正SHR分别为1.78(p=0.007)、1.69(p=0.002)、1.62(p=0.001)。
  • 移除等待名单(移植、死亡或退出)时中位LAS:OLD 75.1,PAH 79.6,CF 91.0,ILD 88.3(p<0.001)。

临床怎么用

  • 临床中需关注ECMO桥接的PAH患者移植机会可能低于其他诊断群体。
  • 当前LAS未明确纳入ECMO状态,可能影响PAH患者的分配公平性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is increasingly utilized as a bridge to lung transplantation, but ECMO status is not explicitly accounted for in the Lung Allocation Score (LAS). We hypothesized that among waitlist patients on ECMO, patients with pulmonary arterial hypertension (PAH) would have lower transplantation rates. METHODS: Using United Network for Organ Sharing data, we conducted a retrospective cohort study of patients who were ≥12 years old, active on the lung transplant waitlist, and required ECMO support from June 1, 2015 through June 12, 2020. Multivariable competing risk analysis was used to examine waitlist outcomes. RESULTS: 1064 waitlist subjects required ECMO support; 40 (3.8%) had obstructive lung disease (OLD), 97 (9.1%) had PAH,138 (13.0%) had cystic fibrosis (CF), and 789 (74.1%) had interstitial lung disease (ILD). Ultimately, 671 (63.1%) underwent transplant, while 334 (31.4%) died or were delisted. The transplant rate per person-years on the waitlist on ECMO was 15.41 for OLD, 6.05 for PAH, 15.66 for CF, and 15.62 for ILD. Compared to PAH patients, OLD, CF, and ILD patients were 78%, 69%, and 62% more likely to undergo transplant throughout the study period, respectively (adjusted SHRs 1.78 p = 0.007, 1.69 p = 0.002, and 1.62 p = 0.001). The median LAS at waitlist removal for transplantation, death, or delisting were 75.1 for OLD, 79.6 for PAH, 91.0 for CF, and 88.3 for ILD (p < 0.001). CONCLUSIONS: Among patients bridging to transplant on ECMO, patients with PAH had a lower transplantation rate than patients with OLD, CF, and ILD.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Furfaro D, Rosenzweig EB, Shah L, et al. Lung transplantation disparities based on diagnosis for patients bridging to transplant on extracorporeal membrane oxygenation. J Heart Lung Transplant. 2021. PMID: 34548196. doi:10.1016/j.healun.2021.08.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。